Aug 20, 2026 07:04AM
Aug 20, 2026 07:00AM
Aug 10, 2026 04:05PM
Aug 6, 2026 07:00AM
Aug 6, 2026 07:00AM
Jul 20, 2026 08:00AM
Jul 20, 2026 08:00AM Samsung Bioepis and Harrow Present Interim Data from a Large-Scale Post-Marketing Surveillance Study on SB11 (BYOOVIZ® / AMELIVU®), a Biosimilar to Lucentis (ranibizumab), at ASRS 2026
Jul 20, 2026 07:01AM
Jul 20, 2026 07:00AM
Jul 1, 2026 07:00AM
Jul 1, 2026 07:00AM
Jun 10, 2026 07:01AM
Jun 10, 2026 07:00AM
May 11, 2026 04:05PM Harrow Announces First Quarter 2026 Financial Results
Apr 16, 2026 07:00AM
Mar 18, 2026 07:00AM
Mar 3, 2026 07:02AM
Mar 3, 2026 07:00AM
Mar 2, 2026 04:05PM
Feb 17, 2026 07:00AM
Feb 4, 2026 06:48AM B.Riley Reiterates Buy Rating on Harrow Health (HROW)
Feb 2, 2026 07:02AM
Feb 2, 2026 07:00AM
Nov 18, 2025 07:01AM
Nov 18, 2025 07:00AM
Nov 10, 2025 04:05PM
Oct 6, 2025 07:00AM
Oct 6, 2025 07:00AM ImprimisRx Announces Leadership Changes
Sep 26, 2025 07:00AM
Sep 26, 2025 07:00AM
Sep 25, 2025 04:06PM
Sep 25, 2025 04:05PM
Sep 23, 2025 06:45AM
Sep 15, 2025 07:00AM
Aug 11, 2025 04:01PM Harrow Announces Second-Quarter 2025 Financial Results
Jul 17, 2025 07:00AM
Jul 17, 2025 07:00AM
Jun 18, 2025 07:00AM
Jun 9, 2025 07:03AM
Jun 9, 2025 07:00AM
May 8, 2025 04:01PM
Apr 10, 2025 07:00AM Harrow Expands VEVYE® Access for All Program to ImprimisRx’s Klarity-C Patients
Mar 27, 2025 04:01PM
Mar 24, 2025 07:05AM
Mar 24, 2025 07:00AM
Mar 17, 2025 04:01PM
Mar 17, 2025 07:00AM
Mar 11, 2025 07:00AM
Jan 27, 2025 07:30AM Harrow Partners with Cencora to Launch “Harrow Cares” Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their Patients
Jan 7, 2025 07:01AM

1,188,044 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All